Artigos com autorizações de acesso público - George BakrisSaiba mais
26 artigos não disponíveis publicamente
Combination therapy in hypertension
AH Gradman, JN Basile, BL Carter, GL Bakris, ...
Journal of the American Society of Hypertension 4 (2), 90-98, 2010
Autorizações: US National Institutes of Health
Mineralocorticoid receptor antagonists in diabetic kidney disease—Mechanistic and therapeutic effects
J Barrera-Chimal, I Lima-Posada, GL Bakris, F Jaisser
Nature Reviews Nephrology 18 (1), 56-70, 2022
Autorizações: Agence Nationale de la Recherche
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, USA …
WB White, JR Turner, DA Sica, JD Bisognano, DA Calhoun, ...
Journal of the American Society of Hypertension 8 (10), 743-757, 2014
Autorizações: US National Institutes of Health
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease
G Bakris, A Briasoulis, B Dahlof, K Jamerson, MA Weber, RY Kelly, ...
The American journal of cardiology 112 (2), 255-259, 2013
Autorizações: US National Institutes of Health
The role of vasodilating β-blockers in patients with hypertension and the cardiometabolic syndrome
AA Taylor, GL Bakris
The American journal of medicine 123 (7), S21-S26, 2010
Autorizações: US National Institutes of Health
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial
JP Ferreira, A Sharma, C Mehta, G Bakris, P Rossignol, WB White, ...
Clinical Research in Cardiology 110, 1006-1019, 2021
Autorizações: Fonds de recherche du Québec - Santé, Agence Nationale de la Recherche
Impact of finerenone-induced albuminuria reduction on chronic kidney disease outcomes in type 2 diabetes: a mediation analysis
R Agarwal, W Tu, AE Farjat, YMK Farag, R Toto, S Kaul, R Lawatscheck, ...
Annals of internal medicine 176 (12), 1606-1616, 2023
Autorizações: US National Institutes of Health, US Department of Veterans Affairs
New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval
F Zannad, P Rossignol, WG Stough, M Epstein, MAA Garcia, GL Bakris, ...
International journal of cardiology 216, 46-51, 2016
Autorizações: National Institute of Health and Medical Research, France
Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic …
RA Phillips, V Fonseca, RE Katholi, JB McGill, FH Messerli, DSH Bell, ...
Journal of the cardiometabolic syndrome 3 (4), 211-217, 2008
Autorizações: US National Institutes of Health
Red cell distribution width in patients with diabetes and myocardial infarction: an analysis from the EXAMINE trial
JP Ferreira, Z Lamiral, G Bakris, C Mehta, WB White, F Zannad
Diabetes, Obesity and Metabolism 23 (7), 1580-1587, 2021
Autorizações: Agence Nationale de la Recherche
The current state of RAAS blockade in the treatment of hypertension and proteinuria
RG Kalaitzidis, GL Bakris
Current cardiology reports 11 (6), 436-442, 2009
Autorizações: US National Institutes of Health
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome
X Rossello, JP Ferreira, F Caimari, Z Lamiral, A Sharma, C Mehta, ...
Clinical Research in Cardiology 110 (10), 1612-1624, 2021
Autorizações: Fonds de recherche du Québec - Santé
Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease
CJ McMullan, Y Yano, GL Bakris, K Kario, RA Phillips, JP Forman
Journal of the American Society of Hypertension 9 (4), 299-306, 2015
Autorizações: US National Institutes of Health
Relation of serum and urine renal biomarkers to cardiovascular risk in patients with type 2 diabetes mellitus and recent acute coronary syndromes (from the EXAMINE Trial)
M Vaduganathan, WB White, DM Charytan, DA Morrow, Y Liu, F Zannad, ...
The American journal of cardiology 123 (3), 382-391, 2019
Autorizações: US National Institutes of Health
Novel antihypertensive agents for resistant hypertension: what does the future hold?
VD Salvador, GL Bakris
Hypertension Research 45 (12), 1918-1928, 2022
Autorizações: US National Institutes of Health
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension
JB Byrd, G Bakris, K Jamerson
Current hypertension reports 16, 1-5, 2014
Autorizações: US National Institutes of Health
Mineralocorticoid receptor antagonists in the treatment of diabetic kidney disease: their application in the era of SGLT2 inhibitors and GLP-1 receptor agonists
S Cohen, H Sternlicht, GL Bakris
Current diabetes reports 22 (5), 213-218, 2022
Autorizações: US National Institutes of Health
Timing of randomization after an acute coronary syndrome in patients with type 2 diabetes mellitus
M Elharram, A Sharma, W White, G Bakris, P Rossignol, C Mehta, ...
American heart journal 229, 40-51, 2020
Autorizações: Fonds de recherche du Québec - Santé, Agence Nationale de la Recherche
Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: insights from AQUARIUS
R Puri, SE Nissen, V Menon, M Shao, A Hsu, GL Bakris, JJP Kastelein, ...
Atherosclerosis 243 (2), 553-559, 2015
Autorizações: National Institute for Health Research, UK
Renal denervation: one step backwards, three steps forward
MP Schlaich, GL Bakris
Nature Reviews Nephrology 14 (10), 602-604, 2018
Autorizações: National Health and Medical Research Council, Australia
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador